CL - Colgate-Palmolive Company
NEXT EARNINGS:
Apr 24, 2026
EPS Est: $0.95
|
Rev Est: $5.2B
Price:
--
--
|
CONSENSUS:
Hold
DETAILS
|
PRICE TARGET:
$92.45
DETAILS
HIGH:
$100.00
LOW:
$85.00
MEDIAN:
$93.00
CONSENSUS:
$92.45
DOWNSIDE:
5.77%
Market Cap:
79.08B
Volume:
5,404,297
Avg Volume:
6,699,335
52 Week Range:
74.55-100.18
Sector:
Consumer Defensive
Industry:
Household & Personal Products
Beta:
0.29
Last Dividend:
$2.08
Exchange:
NYSE
Country:
US
Employees:
34,000
IPO Date:
1973-05-02
EPS (TTM):
2.64
P/E Ratio:
29.97
Revenue (TTM):
20.38B
Total Assets:
16.33B
Total Debt:
7.99B
Cash & Equiv:
1.29B
Rev Growth (5Y):
4.4%
EPS Growth (5Y):
-3.5%
FCF Growth (5Y):
1.9%
ROCE:
31.4%
Debt/Equity:
147.93
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2026-01-30 | $0.95 | $0.91 | +4.2% | $5.2B | $5.1B | +2.1% |
| 2025-10-31 | $0.91 | $0.89 | +2.4% | $5.1B | $5.1B | 0.0% |
| 2025-08-01 | $0.92 | $0.90 | +2.6% | $5.1B | $5.0B | +1.5% |
| 2025-04-25 | $0.91 | $0.86 | +6.3% | $4.9B | $4.9B | +0.9% |
| 2025-01-31 | $0.91 | $0.90 | +1.1% | $4.9B | $5.0B | -0.7% |
| 2024-10-25 | $0.91 | $0.89 | +2.2% | $5.0B | $5.0B | +0.5% |
| 2024-07-26 | $0.91 | $0.87 | +4.6% | $5.1B | $5.0B | +1.1% |
| 2024-04-26 | $0.86 | $0.81 | +6.2% | $5.1B | $5.0B | +2.1% |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 20.38B | 20.10B | 19.46B | 17.97B | 17.42B | 16.47B | 15.69B | 15.54B | 15.45B | 15.20B | 16.03B | 17.28B |
| Net Income | 2.13B | 2.89B | 2.30B | 1.78B | 2.17B | 2.69B | 2.37B | 2.40B | 2.02B | 2.44B | 1.38B | 2.18B |
| EPS | 2.64 | 3.53 | 2.78 | 2.13 | 2.56 | 3.15 | 2.76 | 2.76 | 2.30 | 2.74 | 1.53 | 2.38 |
| Total Assets | 16.33B | 16.05B | 16.39B | 15.73B | 15.04B | 15.92B | 15.03B | 12.16B | 12.68B | 12.12B | 11.96B | 13.46B |
| Total Debt | 7.99B | 8.51B | 9.06B | 9.27B | 7.83B | 8.21B | 8.48B | 6.37B | 6.58B | 6.53B | 6.55B | 6.15B |
| Cash & Equivalents | 1.29B | 1.10B | 966.00M | 775.00M | 832.00M | 888.00M | 883.00M | 726.00M | 1.53B | 1.31B | 970.00M | 1.09B |
| Operating Cash Flow | 4.20B | 4.11B | 3.75B | 2.56B | 3.33B | 3.72B | 3.13B | 3.06B | 3.05B | 3.14B | 2.95B | 3.30B |
| Free Cash Flow | 3.63B | 3.55B | 3.04B | 1.86B | 2.76B | 3.31B | 2.80B | 2.62B | 2.50B | 2.55B | 2.26B | 2.54B |
| FCF per Share | 4.49 | 4.34 | 3.67 | 2.22 | 3.26 | 3.86 | 3.26 | 3.01 | 2.84 | 2.86 | 2.50 | 2.78 |
| Book Value | 54.00M | 212.00M | 609.00M | 401.00M | 609.00M | 743.00M | 117.00M | (102.00M) | (60.00M) | (243.00M) | (299.00M) | 1.15B |
| Cash & ST Investments | 1.29B | 1.26B | 966.00M | 775.00M | 832.00M | 888.00M | 883.00M | 726.00M | 1.53B | 1.31B | 970.00M | 1.09B |
| ROC Equity | 39.48 | 13.63 | 3.78 | 4.45 | 3.56 | 3.63 | 20.23 | N/A | N/A | N/A | N/A | 1.90 |